Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,892 | 120 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $592.69 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $255.85 | 17 | $0 (2024) |
| Novo Nordisk Inc | $242.24 | 14 | $0 (2024) |
| Lilly USA, LLC | $120.67 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $86.24 | 5 | $0 (2024) |
| Dexcom, Inc. | $65.05 | 4 | $0 (2023) |
| PFIZER INC. | $59.69 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $53.01 | 3 | $0 (2024) |
| Amgen Inc. | $42.77 | 2 | $0 (2021) |
| UPSHER-SMITH LABORATORIES LLC | $34.22 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $597.82 | 37 | ABBVIE INC. ($190.17) |
| 2023 | $634.13 | 39 | ABBVIE INC. ($168.50) |
| 2022 | $238.65 | 15 | ABBVIE INC. ($82.53) |
| 2021 | $421.50 | 29 | AbbVie Inc. ($151.49) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Diabetes Care | ||||||
| 09/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Diabetes | ||||||
| 07/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: VTE | ||||||
| 07/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Obesity | ||||||
| 05/30/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: ADHD | ||||||
| 05/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: RESPIRATORY | ||||||
| 04/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Biological | ||||||
| 04/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,008 | 1,225 | $240,229 | $70,967 |
| 2022 | 9 | 852 | 1,079 | $202,483 | $55,844 |
| 2021 | 10 | 960 | 1,178 | $230,125 | $66,166 |
| 2020 | 10 | 825 | 1,054 | $187,260 | $51,754 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 515 | 706 | $124,962 | $32,230 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 153 | 153 | $38,862 | $15,753 | 40.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 48 | 51 | $27,693 | $8,831 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 71 | $17,821 | $4,401 | 24.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 21 | $8,421 | $2,477 | 29.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 71 | $7,881 | $1,997 | 25.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,550 | $1,850 | 40.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,225 | $1,715 | 40.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,960 | $852.84 | 21.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 13 | 14 | $868.00 | $595.18 | 68.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 74 | 82 | $656.00 | $180.40 | 27.5% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 11 | $330.00 | $84.69 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 492 | 696 | $124,584 | $31,061 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 96 | 96 | $24,672 | $10,089 | 40.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 33 | 34 | $18,598 | $5,720 | 30.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 19 | 19 | $7,714 | $2,503 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 84 | 95 | $10,640 | $2,332 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 36 | $9,072 | $2,276 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $5,967 | $1,306 | 21.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 12 | 12 | $840.00 | $415.44 | 49.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 55 | 64 | $396.00 | $142.33 | 35.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 520 | 697 | $125,447 | $34,077 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 83 | 83 | $21,589 | $8,906 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 111 | $26,945 | $6,367 | 23.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 24 | 25 | $13,385 | $4,417 | 33.0% |
About Kristin Haddock, APRN
Kristin Haddock, APRN is a Family healthcare provider based in Aiken, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053384073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristin Haddock, APRN has received a total of $1,892 in payments from pharmaceutical and medical device companies, with $597.82 received in 2024. These payments were reported across 120 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,892).
As a Medicare-enrolled provider, Haddock has provided services to 3,645 Medicare beneficiaries, totaling 4,536 services with total Medicare billing of $244,731. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Aiken, SC
- Active Since 02/09/2006
- Last Updated 03/07/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1053384073
Products in Payments
- TRELEGY ELLIPTA (Drug) $255.85
- VRAYLAR (Drug) $235.73
- QULIPTA (Drug) $173.39
- Ozempic (Drug) $142.92
- UBRELVY (Drug) $142.46
- Dexcom G6 Transmitter (Medical Supply) $65.05
- JARDIANCE (Drug) $64.41
- Rybelsus (Drug) $54.31
- FARXIGA (Drug) $53.01
- Veozah (Drug) $47.85
- Wegovy (Drug) $45.01
- Aimovig (Biological) $42.77
- LINZESS (Drug) $41.11
- MOUNJARO (Drug) $39.08
- Myrbetriq (Drug) $38.39
- TOSYMRA (Drug) $34.22
- Cologuard Collection Kit (Device) $32.10
- QUVIVIQ (Drug) $30.84
- REXULTI (Drug) $27.12
- ELIQUIS (Drug) $27.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Aiken
Dana Dudley, Np, NP
Family — Payments: $12,523
Tina Nordeen, Np, NP
Family — Payments: $11,920
Lindsay Hammett, Fnp, FNP
Family — Payments: $6,203
Latrice Shell
Family — Payments: $3,767
Mrs. Rachel Gay
Family — Payments: $3,534
Mrs. Anna Allman, Fnp, FNP
Family — Payments: $2,169